An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment

被引:48
作者
Gallagher, J. Christopher
Rapuri, Prema B.
Smith, Lynette M.
机构
[1] Creighton Univ, Med Ctr, Bone Metab Unit, Sch Med, Omaha, NE 68131 USA
[2] Univ Nebraska, Med Ctr, Dept Prevent & Societal Med, Omaha, NE 68198 USA
关键词
D O I
10.1210/jc.2006-1153
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Context: Decreased calcitriol production due to impaired renal function may be a significant risk factor for falls in normal aging population. Objective: The objective of the study was to examine the association between creatinine clearance (CrCl) and the incidence of falls and fallers in groups treated with placebo, calcitriol, estrogen therapy (ET)/estrogen + progestin therapy (HT), and calcitriol + ET/HT. Design: This was a 3-yr, double-blind, placebo-controlled study designed to test the efficacy of calcitriol and ET/HT on bone loss and falls with analysis by intention to treat and post hoc. Setting: The study was conducted at an academic outpatient center. Participants: Four hundred eighty-nine normal elderly women aged 65-77 yr; 415 women completed the study. Intervention: Subjects were randomized to placebo, calcitriol 0.25 mu g twice a day, ET daily (conjugated equine estrogens 0.625 mg), HT (conjugated equine estrogen 0.625 mg + medroxyprogesterone acetate 2.5 mg) and calcitriol + ET/HT. Main Outcome Measures: Cumulative number of falls and fallers were compared between groups with 24-h urine CrCl less than 60 and 60 ml/min or greater. Results: Calcitriol treatment decreased the number of fallers and falls. Low CrCl less than 60 ml/min was a predictor of the number of falls per person but not fallers in the placebo group (P = 0.007). In the low CrCl group (< 60 ml/min), the rate of falls decreased on calcitriol by 53% [95% confidence interval (CI) -71% to -22%; P = 0.003], calcitriol + ET/HT by 61% (95% CI -76% to -37%; P = 0.001), and ET/HT by 25% (95% CI: -55% to -24%; not significant). Calcitriol reduced the rate of falls by 30% (95% CI -49% to -4%; P = 0.027) in the CrCl 60 ml/min or greater group. Conclusion: Calcitriol treatment decreases falls in all subjects but especially in elderly women with decreased renal function (< 60 ml/min) and frequent fallers.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 40 条
[1]
Circumstances and consequences of falls in independent community-dwelling older adults [J].
Berg, WP ;
Alessio, HM ;
Mills, EM ;
Tong, C .
AGE AND AGEING, 1997, 26 (04) :261-268
[2]
Risk factors for serious fall related injury in elderly women living at home [J].
Bergland, A ;
Wyller, TB .
INJURY PREVENTION, 2004, 10 (05) :308-313
[3]
Effects of vitamin D and calcium supplementation on falls:: A randomized controlled trial [J].
Bischoff, HA ;
Stähelin, HB ;
Dick, W ;
Akos, R ;
Knecht, M ;
Salis, C ;
Nebiker, M ;
Theiler, R ;
Pfeifer, M ;
Begerow, B ;
Lew, RA ;
Conzelmann, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (02) :343-351
[4]
Muscle strength in the elderly: Its relation to vitamin D metabolites [J].
Bischoff, HA ;
Stahelin, HB ;
Urscheler, N ;
Ehrsam, R ;
Vonthein, R ;
Perrig-Chiello, P ;
Tyndall, A ;
Theiler, R .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1999, 80 (01) :54-58
[5]
Bischoff-Ferrari HA, 2006, ARCH INTERN MED, V166, P424
[6]
Vitamin D receptor expression in human muscle tissue decreases with age [J].
Bischoff-Ferrari, HA ;
Borchers, M ;
Gudat, F ;
Dürmüller, U ;
Stähelin, HB ;
Dick, W .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (02) :265-269
[7]
Combined calcium and vitamin D3 supplementation in elderly women:: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk:: The Decalyos II study [J].
Chapuy, MC ;
Pamphile, R ;
Paris, E ;
Kempf, C ;
Schlichting, M ;
Arnaud, S ;
Garnero, P ;
Meunier, PJ .
OSTEOPOROSIS INTERNATIONAL, 2002, 13 (03) :257-264
[8]
In elderly men and women treated for osteoporosis a low creatinine clearance of &lt;65 ml/min is a risk factor for falls and fractures [J].
Dukas, L ;
Schacht, E ;
Stähelin, HB .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) :1683-1690
[9]
Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of &lt;65 ml/min [J].
Dukas, L ;
Schacht, E ;
Mazor, Z ;
Stähelin, HB .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (02) :198-203
[10]
Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily [J].
Dukas, L ;
Bischoff, HA ;
Lindpaintner, LS ;
Schacht, E ;
Birkner-Binder, D ;
Damm, TN ;
Thalmann, B ;
Stähelin, HB .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (02) :230-236